Shin-nosuke Hashikawa
Impact in
- Biotechnology top 5%
- Enzyme Production and Characterization
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- Clostridium difficile and Clostridium perfringens research 2
- Surgery 6
- Helicobacter pylori-related gastroenterology studies 5
- Co-authors
- Michio Ohta (12 shared papers)Tadao Hasegawa (8 shared papers)Keizo Torii (6 shared papers)Toshiyoshi Araki (4 shared papers)Yoshitsugu Iinuma (3 shared papers)Kenji Yasuda (3 shared papers)Hiromi Sakamoto (3 shared papers)Teruko Ohkura (1 shared paper)
- Journals
- Applied and Environmental Microbiology (2 papers)Journal of Bacteriology (1 paper)Journal of Clinical Microbiology (1 paper)Apmis (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Shin-nosuke Hashikawa
19 papers receiving 588 citations
Peers
Comparison fields: 5 of 69
- Biotechnology 124
- Infectious Diseases 217
- Clinical Biochemistry 74
- Endocrinology 44
- Public Health, Environmental and Occupational Health 240
Countries citing papers authored by Shin-nosuke Hashikawa
This map shows the geographic impact of Shin-nosuke Hashikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin-nosuke Hashikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin-nosuke Hashikawa more than expected).
Fields of papers citing papers by Shin-nosuke Hashikawa
This network shows the impact of papers produced by Shin-nosuke Hashikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin-nosuke Hashikawa. The network helps show where Shin-nosuke Hashikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Shin-nosuke Hashikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 147 | |
| 2 | 2005 | 53 | |
| 3 | 2000 | 46 | |
| 4 | 2006 | 42 | |
| 5 | 2000 | 42 | |
| 6 | 2006 | 41 | |
| 7 | 2004 | 40 | |
| 8 | 2002 | 39 | |
| 9 | 1999 | 33 | |
| 10 | 2004 | 28 | |
| 11 | 2007 | 28 | |
| 12 | 2010 | 25 | |
| 13 | 2002 | 23 | |
| 14 | 2002 | 15 | |
| 15 | 2005 | 5 | |
| 16 | 2021 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2021 | 0 |
About Shin-nosuke Hashikawa
Shin-nosuke Hashikawa is a scholar working on Infectious Diseases, Surgery, Public Health, Environmental and Occupational Health, Nutrition and Dietetics and Molecular Biology, having authored 20 papers that have together received 613 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Streptococcal Infections and Treatments (6 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Microbial Metabolites in Food Biotechnology (4 papers), Enzyme Production and Characterization (4 papers), Biofuel production and bioconversion (3 papers), Veterinary medicine and infectious diseases (3 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Biotechnology (124 citations), Infectious Diseases (217 citations), Clinical Biochemistry (74 citations), Endocrinology (44 citations) and Public Health, Environmental and Occupational Health (240 citations). Shin-nosuke Hashikawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Michio Ohta, Tadao Hasegawa, Keizo Torii, Toshiyoshi Araki, Yoshitsugu Iinuma, Kenji Yasuda, Hiromi Sakamoto, Teruko Ohkura, Toshi Nada and Manabu Furushita. Their work appears in journals such as Applied and Environmental Microbiology, Journal of Bacteriology, Journal of Clinical Microbiology, Apmis and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.